MenB vaccine focal point as NIAC meets

By Lloyd Mudiwa. Consideration should be given to conducting a health technology assessment (HTA) related to a vaccination scheme for high-risk groups against meningococcal B disease, a team of leading public health doctors has recommended.   The proposal came ahead of the National Immunisation Advisory Committee on vaccinations’ meeting this week (March 24), to discuss potential implementation of the vaccine to the immunisation schedule.   Meningitis kills one in 10 of those affected and up to 20 per cent of survivors will suffer after-effects such as brain damage, amputations and hearing loss.   The vaccine Bexsero, which is available on…